US8815212B2ActiveUtilityPatentIndex 41
Nanocarriers for imaging and therapy applications
Est. expirySep 21, 2029(~3.2 yrs left)· nominal 20-yr term from priority
A61K 9/0004A61K 47/30A61K 47/24A61K 49/225A61K 47/06A61K 9/5115A61K 9/5169A61K 9/0009A61K 49/226A61K 49/221A61K 47/42A61K 9/14A61K 49/00
41
PatentIndex Score
1
Cited by
15
References
13
Claims
Abstract
Nanocarriers and methods of preparation and use of nanocarriers are presented. In some embodiments, a nanocarrier composition comprises an organic liquid comprising a plurality of nanoparticles dispersed therein; and a coating material disposed around the exterior surface of the organic liquid. Biological tissue may be imaged or treated by coming into contact with a nanocarrier composition, and, at least in some embodiments, irradiated.
Claims
exact text as granted — not AI-modifiedWhat is claimed is:
1. A method of imaging comprising:
providing a nanocarrier contrast agent composition comprising:
an organic liquid comprising a plurality of nanoparticles dispersed therein, and
a coating material disposed around the exterior surface of the organic liquid;
applying energy to a biological tissue comprising the nanocarrier composition, wherein applying energy to the biological tissue results in at least partial vaporization of the organic liquid; and
imaging a biological tissue comprising the nanocarrier contrast agent composition.
2. The method of claim 1 , wherein applying energy to the biological tissue comprises irradiating at least a portion of the biological tissue with a light source or applying a radio frequency field.
3. The method of claim 1 , wherein the nanocarrier contrast agent further comprises a therapeutic agent.
4. The method of claim 3 , wherein applying energy to the biological tissue results in release of the therapeutic agent from the nanocarrier composition.
5. The method of claim 1 , wherein imaging the biological tissue comprises application of at least one imaging technique selected from the group consisting of: photoacoustic imaging, ultrasound imaging, optical imaging, magnetic resonance imaging, computed tomography, thermal imaging, nuclear imaging, magnetomotive imaging enhancement, and a combination thereof.
6. A method of therapy comprising:
contacting a biological tissue with a nanocarrier contrast agent composition comprising:
an organic liquid comprising a plurality of nanoparticles dispersed therein,
a coating material disposed around the exterior surface of the organic liquid, and
a therapeutic agent; and
applying energy to the biological tissue, wherein applying energy to the biological tissue results in at least partial vaporization of the organic liquid.
7. The method of claim 6 , wherein applying energy to the biological tissue results in release of the therapeutic agent from the nanocarrier contrast agent composition.
8. The method of claim 7 , wherein applying energy to the biological tissue comprises irradiating at least a portion of the biological tissue with a light source or applying a radio frequency field.
9. The method of claim 6 , wherein the therapeutic agent is in the organic liquid.
10. The method of claim 6 , wherein the therapeutic agent is on the exterior surface of the nanocarrier composition.
11. The method of claim 6 , wherein the nanocarrier contrast agent further comprises a targeting moiety.
12. The method of claim 11 , further comprising:
allowing the nanocarrier contrast agent to accumulate in a region of the biological tissue, wherein the targeting moiety facilitated accumulation of the nanocarrier in the region.
13. The method of claim 11 , wherein the targeting moiety comprises at least one targeting moiety selected from the group consisting of: an antibody, an antibody fragment, a peptide sequence, aptamer, folate, a ligand, a gene component, and a combination thereof.Cited by (0)
No later patents cite this yet.
References (0)
No backward citations on record.